Targeting transcription factor NFkappaB: comparative analysis of proteasome and IKK inhibitors.
about
FER tyrosine kinase (FER) overexpression mediates resistance to quinacrine through EGF-dependent activation of NF-kappaBEffect of natural and semisynthetic pseudoguianolides on the stability of NF-κB:DNA complex studied by agarose gel electrophoresisInflammation meets cancer, with NF-κB as the matchmakerMCPIP1 contributes to the toxicity of proteasome inhibitor MG-132 in HeLa cells by the inhibition of NF-κBQuinacrine overcomes resistance to erlotinib by inhibiting FACT, NF-κB, and cell-cycle progression in non-small cell lung cancerThe NF-kappaB activation pathways, emerging molecular targets for cancer prevention and therapyMG132 inhibition of proteasome blocks apoptosis induced by severe DNA damage.Suppression of NF-κB and NF-κB-Regulated Gene Expression by Apigenin through IκBα and IKK Pathway in TRAMP Mice.Synthesis and Evaluation of Macrocyclic Peptide Aldehydes as Potent and Selective Inhibitors of the 20S Proteasome.Targeting IκB Kinase β/NF-κB Signaling in Human Prostate Cancer by a Novel IκB Kinase β Inhibitor CmpdA.Magnetic nanoparticles of Fe3O4 enhance docetaxel-induced prostate cancer cell death.Proteasome inhibition increases recruitment of IκB kinase β (IKKβ), S536P-p65, and transcription factor EGR1 to interleukin-8 (IL-8) promoter, resulting in increased IL-8 production in ovarian cancer cells.Targeting NF-κB and HIF-1 pathways for the treatment of cancer: part I.Regulation of NF-κB by ubiquitination and degradation of the IκBs.Humanin inhibits apoptosis in pituitary tumor cells through several signaling pathways including NF-κB activation.Investigation the mechanism of the apoptosis induced by lactacystin in gastric cancer cells.Proteasome inhibition by bortezomib increases IL-8 expression in androgen-independent prostate cancer cells: the role of IKKα.The role of Rac1 in the regulation of NF-κB activity, cell proliferation, and cell migration in non-small cell lung carcinoma.Flavonoids exert distinct modulatory actions on cyclooxygenase 2 and NF-kappaB in an intestinal epithelial cell line (IEC18).An exploratory clinical trial of bortezomib in patients with lower risk myelodysplastic syndromes.Vasoactive intestinal peptide prevents PKCε-induced intestinal epithelial barrier disruption during EPEC infection.NF-κB p65 subunit DNA-binding activity: association with depleted antioxidant levels in breast carcinoma patients.IKKα is required in the intestinal epithelial cells for tumour stemness.Tissue damage and senescence provide critical signals for cellular reprogramming in vivo.Proteasome inhibition induces IKK-dependent interleukin-8 expression in triple negative breast cancer cells: Opportunity for combination therapy
P2860
Q24300387-3D1102D3-95A9-4813-B89E-4304BCFE594EQ28543064-749A2121-94E9-41A3-982E-3E8D0A0C7DD7Q29620242-466A59B7-2B2B-4352-8A51-F22BF0C187DAQ34038263-218EE97C-1D19-4163-AB27-157225B5C290Q34143354-960B4CDC-842C-40A1-94E5-30F009C494F9Q34596902-577AB497-6F56-4CDC-B2E7-9E76B49DF464Q35695025-A96DE9A7-8785-4136-8490-FBB17FAD9C1AQ35778505-448BE9E5-6081-4B2B-B4DB-A262EB8BA206Q36681767-8F71E1BE-261E-4321-86E8-A35D35C9B308Q37075277-A12A1227-5D0A-4AF4-A857-794D10920E6CQ37120640-5B448ED5-B12E-4B63-8370-378EA7F9406AQ37536497-703CB6EB-8205-416B-92D8-187AE31DC9BDQ37882459-FC05865F-93FA-4242-B75D-AA14BAE53A1DQ37995680-5C45316F-745A-4584-9292-989EBE91D197Q38708867-2A07F3EE-1B02-4790-BE7C-F9CEDD2DF36CQ38925409-6170661C-47B5-427F-9803-FAE02E0EE1F0Q39119033-09046817-4E2F-4DD2-BD46-887936137563Q39355557-E7711AB7-D51F-4DD2-918E-2EAA6ACB5F8BQ39677386-24EEF128-B191-40D5-AE59-F1C53A9CAF52Q40261354-5CA50FDA-6475-4DF2-8CE7-10313E91BC7CQ41602366-0BA19B00-9BF2-4132-8E88-78DBD228E4CAQ43549501-A45706EE-4B82-4801-81F8-4488CDE3B58FQ50041873-A74355E2-B54F-4092-8758-57021DE72B28Q51304904-336030A8-9E92-438B-860B-163D21FF4175Q58796147-D8581236-C5CB-4F8C-B6C6-F73603840EFE
P2860
Targeting transcription factor NFkappaB: comparative analysis of proteasome and IKK inhibitors.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Targeting transcription factor ...... proteasome and IKK inhibitors.
@en
Targeting transcription factor ...... proteasome and IKK inhibitors.
@nl
type
label
Targeting transcription factor ...... proteasome and IKK inhibitors.
@en
Targeting transcription factor ...... proteasome and IKK inhibitors.
@nl
prefLabel
Targeting transcription factor ...... proteasome and IKK inhibitors.
@en
Targeting transcription factor ...... proteasome and IKK inhibitors.
@nl
P2093
P356
P1433
P1476
Targeting transcription factor ...... proteasome and IKK inhibitors.
@en
P2093
Alexander A Shishkin
Alexander V Gasparian
Alexander Y Yemelyanov
Dmitry V Chebotaev
Irina V Budunova
Olga A Guryanova
P304
P356
10.4161/CC.8.10.8415
P577
2009-05-13T00:00:00Z